Publication | Closed Access

P-glycoprotein antagonists confer synergistic sensitivity to short-chain ceramide in human multidrug-resistant cancer cells

Tumor BiologyHealth SciencesMedicineImmune Checkpoint InhibitorP-glycoprotein AntagonistsSynergistic SensitivityPharmacotherapyAnti-cancer AgentShort-chain CeramideCancer TreatmentPharmacologyRadiation OncologyCancer ResearchDrug DiscoveryDrug Resistance